Shire Shrugs Off Lifitegrast CRL; Launch Expected In 2016
This article was originally published in The Pink Sheet Daily
Executive Summary
With top-line data from additional Phase III expected this quarter, Shire plans to refile lifitegrast for approval in dry-eye syndrome in early 2016, making approval and launch by the third quarter next-year feasible.